DK0635132T4 - Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener - Google Patents

Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener

Info

Publication number
DK0635132T4
DK0635132T4 DK93907460T DK93907460T DK0635132T4 DK 0635132 T4 DK0635132 T4 DK 0635132T4 DK 93907460 T DK93907460 T DK 93907460T DK 93907460 T DK93907460 T DK 93907460T DK 0635132 T4 DK0635132 T4 DK 0635132T4
Authority
DK
Denmark
Prior art keywords
react
broadly reactive
opsonic antibodies
staphylococcal antigens
reactive opsonic
Prior art date
Application number
DK93907460T
Other languages
Danish (da)
English (en)
Other versions
DK0635132T3 (da
Inventor
Gerald W Fischer
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26709752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0635132(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Publication of DK0635132T3 publication Critical patent/DK0635132T3/da
Application granted granted Critical
Publication of DK0635132T4 publication Critical patent/DK0635132T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93907460T 1992-03-19 1993-03-18 Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener DK0635132T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85402792A 1992-03-19 1992-03-19
US3347693A 1993-03-18 1993-03-18
PCT/US1993/002275 WO1993019373A1 (fr) 1992-03-19 1993-03-18 Anticorps opsoniques fortement reactifs, reagissant aux antigenes courants des staphylocoques

Publications (2)

Publication Number Publication Date
DK0635132T3 DK0635132T3 (da) 2001-02-26
DK0635132T4 true DK0635132T4 (da) 2008-08-25

Family

ID=26709752

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907460T DK0635132T4 (da) 1992-03-19 1993-03-18 Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener

Country Status (12)

Country Link
EP (3) EP1033135A1 (fr)
JP (3) JP4124816B2 (fr)
AT (1) ATE197506T1 (fr)
AU (1) AU3805893A (fr)
CA (1) CA2132421C (fr)
DE (1) DE69329642T3 (fr)
DK (1) DK0635132T4 (fr)
ES (1) ES2155450T5 (fr)
GR (1) GR3035155T3 (fr)
IL (1) IL105119A (fr)
PT (1) PT635132E (fr)
WO (1) WO1993019373A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US6632432B1 (en) 1990-10-22 2003-10-14 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
DK0783520T3 (da) * 1994-09-21 2002-03-25 Jackson H M Found Military Med Bredt reaktive opsoniske antistoffer, som er reaktive mod fælles stafylokok-antigener
AU2006203322B2 (en) * 1997-06-16 2010-04-29 Altor Bioscience Corporation Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
JP2003503015A (ja) * 1999-05-03 2003-01-28 メダレツクス・インコーポレーテツド スタフィロコッカス・アウレウスに対するヒト抗体
WO2004043407A2 (fr) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Methodes et produits de traitement des infections staphylococciques
WO2004043405A2 (fr) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Vaccin a base de polysaccharide destine a combattre les infections aux staphylocoques
SI1745075T1 (sl) 2004-04-21 2013-07-31 The Brigham And Women's Hospital, Inc. Poli-N-acetilglukozamin (PNAG/dPNAG) vezavni peptidi in postopki za njihovo uporabo
US8445000B2 (en) 2004-10-21 2013-05-21 Wyeth Llc Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens
CA2619784A1 (fr) * 2005-08-23 2007-06-07 Iq Corporation Procedes de production de lymphocytes b stables
PL1821053T3 (pl) 2006-01-31 2016-04-29 Electrolux Home Products Corp Nv Urządzenie do szybkiego schładzania napojów i sposób jego kontrolowania
KR101785373B1 (ko) 2008-07-21 2017-10-16 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
PE20110023A1 (es) 2009-06-22 2011-01-31 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
WO1988004669A1 (fr) * 1986-12-15 1988-06-30 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain et medicament pour la prophylaxie et le traitement de maladies infectieuses comprenant ledit anticorps en tant qu'ingredient efficace
AU673508B2 (en) * 1992-02-25 1996-11-14 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections

Also Published As

Publication number Publication date
JPH07507387A (ja) 1995-08-10
ES2155450T5 (es) 2008-11-01
WO1993019373A1 (fr) 1993-09-30
DE69329642T3 (de) 2009-05-20
IL105119A0 (en) 1993-08-18
CA2132421C (fr) 2010-11-23
GR3035155T3 (en) 2001-04-30
EP0635132B2 (fr) 2008-05-14
IL105119A (en) 1999-06-20
JP2002255998A (ja) 2002-09-11
EP1027896A1 (fr) 2000-08-16
PT635132E (pt) 2001-03-30
DK0635132T3 (da) 2001-02-26
EP0635132B1 (fr) 2000-11-08
JP2007119468A (ja) 2007-05-17
ES2155450T3 (es) 2001-05-16
EP1033135A1 (fr) 2000-09-06
JP4353974B2 (ja) 2009-10-28
DE69329642T2 (de) 2001-03-15
ATE197506T1 (de) 2000-11-11
AU3805893A (en) 1993-10-21
DE69329642D1 (de) 2000-12-14
JP4171596B2 (ja) 2008-10-22
CA2132421A1 (fr) 1993-09-20
JP4124816B2 (ja) 2008-07-23
EP0635132A1 (fr) 1995-01-25

Similar Documents

Publication Publication Date Title
DK0635132T3 (da) Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener
Jürgens et al. Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity.
WO1998057994A3 (fr) Anticorps opsoniques, monoclonaux protecteurs, et chimeres specifiques a l'acide lipoteichoique des bacteries gram positif
McCabe et al. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant
Spika et al. Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome
ATE302411T1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
DE69940545D1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
CA2093928A1 (fr) Anticorps monoclonaux pour la detection et le traitement due cancer
ES2188927T3 (es) Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo.
CA2145397A1 (fr) Vaccins conjugues polysaccharides-proteines contre des streptocoques du groupe b de types ii et v
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK0476226T3 (da) Monoklonalt antistof mod humant IgE
DE69738770D1 (de) Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis
DK0783520T3 (da) Bredt reaktive opsoniske antistoffer, som er reaktive mod fælles stafylokok-antigener
Stinson et al. Binding of streptococcal antigens to muscle tissue in vitro
DE3851630D1 (de) Antikörper gegen streptococcus.
EP0450573A3 (fr) Anticorps pour le traitement et le diagnostic d'infections de Pseudomonas aeruginosa
Genco et al. Purification, characterization, and immunogenicity of cell-associated glucan from Streptococcus mutans
EP0368466A3 (fr) Compositions et méthodesde traitement et de prevention des infections à bacteries gram-negative
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
FI894048A0 (fi) Menetelmä Pseudomonas aeruginosa-infektioita vastaan vaikuttavien valmisteiden sekä immunoglobuliini-G-pitoisten, Pseudomonas aeruginosa-bakteeria vastaan vaikuttavien valmisteiden tuottamiseksi
Bruderer et al. The Use of Antibody Specificity and Affinity in Determining the Protectiveness of Human Monoclonal Antibodies Against Fatal Infections with Nosocomial Gram-Negative Bacteria
IL80918A (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes and pharmaceutical compositions and kits containing said antibodies
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation